Researchers from the University of Technology Sydney (UTS) have published a groundbreaking computational study that clarifies how breathing therapy devices interact with human airways. Published in Respiratory Physiology & Neurobiology, the research utilizes a patient-specific three-dimensional airway model derived from CT imaging to simulate the effects of Continuous High-Frequency Oscillation (CHFO) therapy. This approach provides the first detailed visualization of how pressure and friction vary across different regions of the respiratory system during treatment. Dr. Suvash C. Saha, the lead author and Senior Lecturer at UTS School of Mechanical and Mechatronic Engineering, noted that while CHFO is clinically used to aid airway clearance and lung expansion, the transmission of its oscillatory pressure through the airways had not been accurately measured. The study aimed to fill this gap by mapping how CHFO reshapes pressure, wall shear stress, and wall-normal loading throughout the airway tree under both standard and high-pressure settings. The findings reveal that therapy does not affect all parts of the airway equally. Distinct areas, particularly around the throat and voice box, experience significantly stronger pressure and friction compared to other sections. Conversely, larger upper-airway regions bear more of the overall force. Crucially, the study determined that the individual anatomy of the airway plays the dominant role in determining where mechanical loading is concentrated. Even when therapy settings are adjusted to increase pressure, the location of these high-stress "hot spots" remains fixed by the patient's physical structure. Increasing the pressure setting enhances the strength of the therapeutic support but does not alter the specific locations where the mechanical effects occur. This discovery suggests that simply turning up the device settings is not the solution for improving treatment efficacy. Instead, device parameters must be carefully selected based on the specific anatomical characteristics of each patient and the clinical goals. Dr. Saha emphasized that understanding exactly where and how the therapy acts is essential for improving safety, comfort, and effectiveness. The research highlights the value of using advanced engineering combined with medical science to optimize health care. A computer model based on real human anatomy can reveal critical data that is difficult or impossible to measure directly in patients, enabling doctors to make more informed decisions. The study advocates for a shift toward evidence-based design and testing of respiratory support devices, with a strong push for patient-specific modeling. It also points to the need for future clinical guidelines that consider not only the decision to use a therapy but also how different settings impact various parts of the airway. These insights have the potential to guide the development of next-generation devices and more personalized treatment regimens for patients with conditions such as bronchiectasis, cystic fibrosis, and postoperative atelectasis. By aligning device settings with individual anatomical needs, the research paves the way for safer and more effective respiratory therapies.